TGFB1 and pulmonary fibrosis: The upregulation of TGF-β1 and other growth factors (FGF, EGF), followed by the activation of pro-fibrotic pathways and the renin–angiotensin system imbalance, may also contribute to the development of post-COVID lung fibrosis [24].